Sunday, November 15, 2026 · Agents

From Issue 103 (2026-11-15) · 17 stories in this issue

05 M&A

❯ Oura agrees to buy Counsel Health for $625 million in cash, connecting health monitoring with physician care

An existing partnership becomes a dealOura signed a definitive agreement on November 10 to acquire Counsel Health for $625 million in cash, subject to purchase-price adjustments and customary closing conditions. The companies’ announcement anticipates completion before year-end. They have worked together since May, so the acquisition would bring an existing care platform and physician team into the same corporate organization. Closing remains outstanding.

Biometrics connect to clinical servicesOura Ring continuously tracks sleep, activity and physiological signals, while its app translates those signals into health insights. Counsel combines medical AI with licensed physicians, organizing questions and records before doctors provide diagnoses, prescriptions or referrals where appropriate. With permission, physicians can access Oura data and previous conversations. Oura’s product explanation describes a connected in-app journey from noticing a change to obtaining care, extending beyond a monitoring notification.

An established base supports expansionOura also disclosed preliminary, unaudited revenue of $533 million for its fiscal fourth quarter ended September 30, up 153%, and approximately $1.75 billion for the full year, up 92%. More than six million members provide an existing audience for integrated services. Counsel plans to continue serving enterprise partners, including health plans, health systems and employers. Its potential reach therefore extends beyond people who own an Oura Ring.

Physicians remain part of clinical decisionsCounsel uses specialized agents for tasks such as history-taking, guideline retrieval and record review, with physicians using an integrated clinical interface. The companies plan further connections across preventive, acute and chronic care, but full product integration remains a subsequent step. Oura Ring itself is not a medical diagnostic device. The additional ability to provide clinical treatment comes from Counsel’s service infrastructure and licensed physicians.

▮ SIGNALOura is buying the care infrastructure that can respond to health insights: continuous monitoring identifies needs, while physicians and medical AI handle subsequent care, extending the member relationship into ongoing treatment.